FDA018-ADC

· Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FDA018-ADC, covering 2026-01-22 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FDA018-ADC in Patients With Advanced Solid Tumors [Phase 1]